Purpose: To report on trypan-blue-assisted anterior continuous curvilinear capsulorhexis (ACCC) in a case of ocular pemphigoid.

Methods: Interventional case report.

Results: Due to the reduced visibility especially in the corneal periphery caused by the ocular pemphigoid, trypan blue 0,06% (Acri.Blue) was used to stain the anterior capsule of the lens. Then anterior continuous curvilinear capsulorhexis was performed. Due to the blue staining, the visualization of the margin of the rhexis was always good and phacoemulsification procedure was successfully performed afterwards. During the follow-up period of 12-months-postsurgically, no exacerbation of the ocular pemphigoid occurred.

Conclusions: The use of trypan blue staining of the anterior capsule enabled the surgeon to perform a safe anterior continuous curvilinear capsulorhexis and a subsequent phacoemulsification in ocular pemphigoid. No progression of the ocular pemphigoid was seen within the 12-months-post-surgery period.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273940600889313DOI Listing

Publication Analysis

Top Keywords

ocular pemphigoid
20
anterior continuous
16
continuous curvilinear
16
curvilinear capsulorhexis
16
trypan-blue-assisted anterior
8
case ocular
8
trypan blue
8
anterior capsule
8
blue staining
8
ocular
6

Similar Publications

We present a case of mixed microbial keratitis in an otherwise healthy contact lens wearer. The microbes detected on microscopy included , , , and . and are well-recognised corneal pathogens, although is uncommon, and is extremely rare.

View Article and Find Full Text PDF

Introduction: Combined uveitis-rheumatology clinics (combined clinics) are a relatively recent clinical care model. Here we report the demographics, ocular and systemic disease characteristics, and medications utilized in patients seen in a combined clinic at a tertiary care hospital in the USA.

Methods: Medical records were reviewed of patients seen at the Combined Clinic at the University of Colorado Hospital between January 1, 2016 and November 1, 2023.

View Article and Find Full Text PDF

Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230.

Front Immunol

December 2024

Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.

Background: Bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP) are rare autoimmune blistering disorders characterized by autoantibodies (autoAbs) targeting dermo-epidermal junction components such as BP180 and BP230. The differential diagnosis, based on both the time of appearance and the extension of cutaneous and/or mucosal lesions, is crucial to distinguish these diseases for improving therapy outcomes and delineating the correct prognosis; however, in some cases, it can be challenging. In addition, negative results obtained by commercially available enzyme-linked immunosorbent assays (ELISAs) with BP and MMP sera, especially from patients with ocular involvement, often delay diagnosis and treatment, leading to a greater risk of poor outcomes.

View Article and Find Full Text PDF

Purpose: To develop a novel grading scale for assessing conjunctival inflammation in cicatrizing conjunctivitis associated with Pemphigoid.

Methods: We performed a retrospective analysis of digital slit-lamp images for patients with cicatricial pemphigoid in which best-quality conjunctival images for each eyelid at each photographic session was selected and anonymized. These images were subsequently prospectively assessed for inflammation severity on a scale of 0-4+ by a fellowship-trained ophthalmologist specializing in pemphigoid.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!